How to make sure we all benefit when nonprofits patent technologies like CRISPRWTOPQuestions like these arose recently in the case of CRISPR, the promising new gene-editing technology. After patenting it, the Broad Institute of MIT and Harvard sold the… Continue reading
Phys.Org |
Parasitic worms may lead to agricultural stem cell breakthrough
Phys.Org Top: Meloidogyne incognita (aka the southern root-knot nematode) used in the discovery of nematode manipulation of plant stem cells. Bottom left: Dying cucumber plants due to root-knot nematode infection. Bottom right: Galls on the infected …more. |
Forbes |
CAR–T Cell Therapy Is Here to Stay
Forbes After decades of research and development, we’re on the brink of a new era in the treatment of cancer, one where nearly every aspect—from the patient experience to the efficacy of treatments—may be upended. This treatment is known as chimeric antigen … CAR T-cell therapy for leukemia leads to remissions in clinical trialFred Hutch News Service CAR-T gene therapy for leukemia clears FDA hurdle – WsawWSAW |
Forbes |
CAR–T Cell Therapy Is Here To Stay
Forbes After decades of research and development, we’re on the brink of a new era in the treatment of cancer, one where nearly every aspect—from the patient experience to the efficacy of treatments—may be upended. This treatment is known as chimeric antigen … FDA Advisory Committee Recommends Approval of CAR–T Cell Therapy and Two New BiosimilarsLexology (registration) |
NME.com |
Ed Sheeran uses Instagram to help 7-year-old girl find stem cell donor
NME.com Ed Sheeran has taken to Instagram in a life-saving bid to help a seven-year-old girl find a blood stem cell donor. Despite his on-off relationship with Twitter in the wake of the mixed reactions to his ‘Game Of Thrones’ cameo, Sheeran remains active on … Ed Sheeran joins stem cell donor appeal to help sick girlTV3.ie Ed Sheeran Pleads with Fans to Help a Sick ChildRadio.com Music and Entertainment News |
Pharmaceutical Processing |
Epidermolysis Bullosa Gene Therapy Effort Gains FDA Guidance
Pharmaceutical Processing Abeona Therapeutics receives guidance from FDA to commence pivotal phase 3 for EB-101 gene therapy for patients with epidermolysis bullosa. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel gene … Maxim bullish on Abeona, sees 89% upside on prospects of lead gene therapy candidate EB-101; shares up 2%Seeking Alpha Maxim Group Just Issued “Buy” Rating on Abeona Therapeutics Inc (ABEO)Highland Mirror Analysts are on the Bearish side about Abeona Therapeutics Inc (NASDAQ:ABEO) this week.WeeklyHub |